• Home
  • >>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>
  • Virtual Data Room (VDR) for Strategic Customized Slide Decks
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

Danielle Smolyar, Research Assistant 3 – Text Analysis for 2.0 LPBI Group’s TNS #1 – 2020/2021 Academic Internship in Medical Test Analysis (MTA)

Danielle Smolyar, Research Assistant 3 – Text Analysis for 2.0 LPBI Group’s TNS #1 – 2020/2021 Academic Internship in Medical Text Analysis (MTA)

UPDATED on 1/17/2022

NEW GENRE e-Series:

Series C: Cancer Volume 1 – PART B

PART B:

Medical Text Analysis with Wolfram Language for Biological Sciences Symbolic Computation Language for Natural Language Processing (NLP)

 

  • NLP Results
  • Interpretation of NLP Results

 

The article titles listed, below contain the Text CONTENTS included in the Medical Text Analysis with NLP algorithms

 

Preface on the Methodology of Interpretation of NLP Results, and 24 plot interpretation

by

Cancer & Genomics Domain Knowledge Expert

STEPHEN J. WILLIAMS, PhD

 

 

NLP Code writing [PART B Appendix], and

Visualization plot production for Chapters 1 to 12

by

SATWIK SUNNAM

 

Text Preparation for NLP, Chapters 1 to 6

and

New Genre Book Formatting

by

DANIELLE SMOLYAR

 

Text Preparation for NLP, Chapters 7 to 12

by

PREMALATA PATI, PhD

 

Roles @ LPBI:

TASK #1:

USE ONE of the Three following INPUTS to be used in building the Proof of Concept described in

https://pharmaceuticalintelligence.com/2021-medical-text-analysis-nlp/

WordCloud Visualization of LPBI’s Top Twelve Articles by Views at All Time and their Research Categories in the Ontology of PharmaceuticalIntelligence.com

Curators: Daniel Menzin, Noam Steiner-Tomer, Zach Day, Ofer Markman, PhD, Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2020/07/21/wordcloud-visualization-of-lpbis-top-twelve-articles-by-views-at-all-time-and-their-research-categories-in-the-ontology-of-pharmaceuticalintelligence-com/

 

WordCloud Visualization of LPBI’s Top Sixteen Articles on CANCER in eight categories and by Views at All Time and their Research Categories in the Ontology of PharmaceuticalIntelligence.com

Curator: Stephen J. Williams, PhD and WordCloud Producers: Daniel Menzin, Noam Steiner-Tomer, Zach Day, Ofer Markman, PhD and Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2020/07/30/wordcloud-visualization-of-lpbis-top-sixteen-articles-on-cancer-in-eight-categories-and-by-views-at-all-time-and-their-research-categories-in-the-ontology-of-pharmaceuticalintelligence-com/

 

WordCloud Visualization of LPBI’s Top Sixteen Articles on GENOMICS by Views at All Time and their Research Categories in the Ontology of PharmaceuticalIntelligence.com

Curators: Stephen J. Williams, Aviva Lev-Ari, PhD, RN and WordCloud Producers: Daniel Menzin, Noam Steiner-Tomer, Zach Day, Ofer Markman, PhD

https://pharmaceuticalintelligence.com/2020/07/30/wordcloud-visualization-of-lpbis-top-sixteen-articles-on-genomics-by-views-at-all-time-and-their-research-categories-in-the-ontology-of-pharmaceuticalintelligence-com/

TASK #2:

Expand applications of Microsoft AZURE to

Series C: e-Books on Cancer & Oncology

Volume 1:

Cancer Biology and Genomics for Disease Diagnosis

http://www.amazon.com/dp/B013RVYR2K 

Volume 2:

Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery

http://www.amazon.com/dp/B071VQ6YYK 

and

Series B: Frontiers in Genomics Research

Volume 1: 

Genomics Orientations for Personalized Medicine

http://www.amazon.com/dp/B018DHBUO6

Volume 2:

Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS & BioInformatics, Simulations and the Genome Ontology

https://www.amazon.com/dp/B08385KF87

12 categories of Research the Danielle Smolyar wishes to learn more about from the Ontology of LPBI’s Open Access Online Scientific Journal: PharmaceuticalIntelligence.com

  • dental applications 
  • medical device technology for Alzheimer’s diseases
  • endocrine diseases 
  • Molecular genetics and pharmaceutical
  • Neurological diseases
  • Stem cells for regenerative medicine
  • Drug development using multi organ chip
  • Cancer genomics
  • Cancer screening
  • Drug delivery platform technology
  • Gene regulation
  • Clinical genomics

Danielle Smolyar

dsmolyar@syr.edu

617.899.8956

Newton MA, 02469

BIO

EDUCATION

College of Arts and Sciences, Syracuse University, Syracuse, New York
Bachelor of Science in Biology

Expected: May 2022

Classes for 2020/2021:

  • physiology
  • calculus 
  • biochemistry 
  • dynamic of addiction 
  • English writing 

Biology courses 2018/2019: 

  • genetics 
  • cell biology 
  • general biology laboratory 1 and 2 
  • general biology 1 and 2
  • evolutionary biology, religion and society

Gann Academy High School

Graduated In 2018 

2014 – 2018 

  • Half English/ Hebrew day school
  • Danced throughout high school: Won outstanding awards in dance 

EXPERIENCE                                                                                    

Doctoral Intern

Dr. Kathleen Caruso, Newton, MA

July 2016 – Present

  • Shadowed Dr. Caruso in appointments • Performed admin tasks

Dental Intern Assistant

Smolyar Dental, Newton, MA

2019–Present

  • Answered phone calls
  • Managed the front desk
  • Filed papers and scheduled in clients

Owner’s Assistant

Legit Activewear, Newton, MA

2016–2018

  • Communicated with costumers and retail buyers
  • Posted content on all social media platforms
  • Worked the floor and recorded inventory

Dance Assistant

Joanne Langione Dance Center, Newton, MA

2014–2018

  • Assisted instructors
  • Lead the class in choreography
  • Helped with ages 6-16

SKILLS

Microsoft PowerPoint, Word, Excel

Bilingual in Hebrew and English

Instagram, Twitter, Facebook

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email

Like this:

Like Loading…

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,041 other subscribers
  • Recent Posts

    • FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
    • Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
    • In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
    • Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
    • AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
    • In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
    • Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
    • 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
    • Protected: KOL on Competitive Dynamics: LPBI Group’s Founder’s Radar Screens on AI-in-Health, Life Sciences & BioPharma June 15, 2026
    • Tumor Infiltrating Lymphocytes (TIL) as a first of kind FDA approved immunotherapy for cancer June 12, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


Loading Comments...
%d